191 related articles for article (PubMed ID: 33475963)
1. Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer.
Liu X; Chang Q; Wang H; Qian H; Jiang Y
Breast Cancer; 2021 Jul; 28(4):806-821. PubMed ID: 33475963
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
[TBL] [Abstract][Full Text] [Related]
3. The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study.
Tang W; Li GS; Li JD; Pan WY; Shi Q; Xiong DD; Mo CH; Zeng JJ; Chen G; Feng ZB; Huang SN; Rong MH
Pathol Res Pract; 2020 Jan; 216(1):152754. PubMed ID: 31787478
[TBL] [Abstract][Full Text] [Related]
4. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
[TBL] [Abstract][Full Text] [Related]
5. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
6. Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis.
Wang F; Hou J; Jin W; Li J; Yue Y; Jin H; Wang X
Molecules; 2014 May; 19(5):6282-93. PubMed ID: 24840899
[TBL] [Abstract][Full Text] [Related]
7. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
Li S; Yang X; Yang J; Zhen J; Zhang D
Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
[TBL] [Abstract][Full Text] [Related]
9. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
10. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
Si H; Sun X; Chen Y; Cao Y; Chen S; Wang H; Hu C
J Cancer Res Clin Oncol; 2013 Feb; 139(2):223-9. PubMed ID: 23052693
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
Garrido-Cano I; Constâncio V; Adam-Artigues A; Lameirinhas A; Simón S; Ortega B; Martínez MT; Hernando C; Bermejo B; Lluch A; Lopes P; Henrique R; Jerónimo C; Cejalvo JM; Eroles P
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050096
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of serum miR-1204 and its potential as a biomarker for the diagnosis and prognosis of breast cancer.
Han S; Li P; Wang D; Yan H
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):732-736. PubMed ID: 32696863
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer.
Yan LR; Wang A; Lv Z; Yuan Y; Xu Q
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439992
[TBL] [Abstract][Full Text] [Related]
16. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
Liu L; Wang S; Cao X; Liu J
Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
[TBL] [Abstract][Full Text] [Related]
17. Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer.
Adam-Artigues A; Garrido-Cano I; Simón S; Ortega B; Moragón S; Lameirinhas A; Constâncio V; Salta S; Burgués O; Bermejo B; Henrique R; Lluch A; Jerónimo C; Eroles P; Cejalvo JM
ESMO Open; 2021 Feb; 6(1):100039. PubMed ID: 33477007
[TBL] [Abstract][Full Text] [Related]
18. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
19. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
